Merck & CompanyvsVericel

MRK and VCEL stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$147.76

Value $365B

+0.55%
MRK's page

VCEL

Vericel Corporation

$56.96

Value $2.9B

-0.80%
VCEL's page

Merck & Company (MRK) has a market value of $365B and Vericel (VCEL) $2.9B. Over the last year, with dividends, MRK moved +66.3% and VCEL +40.9%. The P/E is 148.9 for MRK and 86.8 for VCEL. Dividend yield: MRK 2.30%, VCEL none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$365B

    VCEL$2.9B

    MRK is 126 times VCEL

  • Revenue, 12 months

    MRK$67.4B

    VCEL$324M

    MRK is 208 times VCEL

  • Net income, 12 months

    MRK$2.5B

    VCEL$33M

    MRK is 74 times VCEL

  • Operating margin

    MRK–

    VCEL8.3%

  • ROIC

    MRK3.9%

    VCEL6.0%

    2.1 points apart

  • P/E

    MRK148.9

    VCEL86.8

    MRK is 1.7 times VCEL

  • Dividend yield

    MRK2.3%

    VCEL0.0%

    2.3 points apart

  • 5-year return

    MRK+104.9%

    VCEL+36.3%

    68.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+104.9%

VCEL+36.3%

5010015020020222023202420252026
Returns by period
PeriodMRKWith dividendsVCELWith dividends
1 year since November 12, 2025+66.3%Price +61.6%+40.9%Price +40.9%
3 years since November 13, 2023+58.0%+16.5% a yearPrice +44.2%+67.8%+18.8% a yearPrice +67.8%
5 years since November 12, 2021+104.9%+15.4% a yearPrice +75.9%+36.3%+6.4% a yearPrice +36.3%
10 years since November 15, 2016+230.1%+12.7% a yearPrice +143.3%+2,323.8%+37.5% a yearPrice +2,323.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanyVCELVericel

Valuation

MRKVCEL
Valuation
Price$147.76$56.96
Market value$365B$2.9B
Enterprise value (EV)$409B–
P/E148.986.8
P/E, 5-year median14.8–
P/B8.17.5
EV/EBIT86.0–
Free cash flow yield4.0%2.0%

Results and growth

MRKVCEL
Results and growth
Revenue, 12 months$67.4B$324M
Net income, 12 months$2.5B$33M
Free cash flow, 12 months$14.7B$58M
Earnings per share, 12 months$0.98$0.64
Revenue growth, year on year1.3%16.5%
Revenue growth a year, past+9.4%over 5 years+17.8%over 5 years
EPS growth a year, past+21.2%over 5 years+39.8%over 5 years

Margins and returns on capital

MRKVCEL
Margins and returns on capital
Gross margin71.8%74.5%
Operating margin–8.3%
Net margin3.6%10.3%
ROIC3.9%6.0%
ROE5.2%9.3%

Balance sheet

MRKVCEL
Balance sheet
Cash$9.7B$170M
Total debt$53.8B–
Net debt / EBITDA5.7–
Interest cover2.4×42.0×

Dividends and buybacks

MRKVCEL
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$3.40–
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.4%–
Shareholder yield3.7%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or VCEL

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or Vericel?

By market value, Merck & Company ($365B) is about 126.3 times Vericel ($2.9B), at today's prices.

How did MRK and VCEL stock do over the last 10 years?

Since November 15, 2016, MRK's price moved +143.3% and VCEL's +2,323.8%. With dividends: MRK +230.1% (+12.7% a year), VCEL +2,323.8% (+37.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or VCEL?

The dividend yield at today's price is 2.30% for Merck & Company and none for Vericel. Over the last twelve months they paid $3.40 and – per share.

What is the P/E of MRK and VCEL?

At today's price, the P/E is 148.9 for MRK and 86.8 for VCEL. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Merck & Company or Vericel?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 10.3% for Vericel, and the operating margin – and 8.3%. Revenue was $67.4B and $324M.

Which is the better investment, Merck & Company or Vericel?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.